However, in our cohort, serum samples were obtained at diagnosis before initiation of HLH disease- or sepsis-directed therapy, and Mann–Whitney U tests with Bonferroni correction did not reveal significant differences in SAA-1 or LRG1 levels between male and female patients or according to the presence of documented comorbidities. This evidence concerns the gene SAA1 and Sepsis.